Article

It’s time to get to know AI

Artificial intelligence will be widely deployed in clinical tools that improve our diagnostic accuracy and provide better personalized data to...

News

New antibody cuts the fat in NAFLD

BOSTON – In a phase 1b trial, treatment with tolerable doses of the bispecific antibody reduced hepatic fat fraction by a mean of 38%.

Pages